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Edited by Robert BaroukiAbstract Tunicamycin is a well-known inhibitor of protein gly-
cosylation and used as an inducer of endoplasmic reticulum (ER)
stress. We found that tunicamycin induced expression of cyto-
chrome P450 1A1 in a dose-dependent manner. Like dioxin,
the transcriptional induction was associated with dose-dependent
activation of the dioxin responsive element (DRE). This eﬀect
was independent of inhibition of protein glycosylation or induc-
tion of ER stress. Pharmacological and genetic inhibition of
the aryl hydrocarbon receptor (AhR) signiﬁcantly attenuated
activation of DRE by tunicamycin. These results elucidated the
novel potential of tunicamycin as an activator of the AhR –
DRE signaling pathway.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Tunicamycin; Cytochrome P450; Dioxin responsive
element; Aryl hydrocarbon receptor1. Introduction
Tunicamycin has been extensively used as inhibitor of lipid
carrier-dependent protein glycosylation and, currently, is
widely used as an inducer of endoplasmic reticulum (ER) stress
[1]. Tunicamycin was originally puriﬁed from Streptomyces
lysosuperiﬁcus as an antibiotic that inhibits cell wall polymer
synthesis [2]. However, its therapeutic usefulness is limited be-
cause of toxicity in mammals. For example, tunicamycin is
hepatotoxic and causes a periportal pattern of damage result-
ing in denudation of hepatocytes into blood vessels, and for-
mation of pulmonary and cerebral emboli [3]. ER stress may
be involved in the toxic eﬀects of tunicamycin, but underlying
mechanisms have not been identiﬁed yet.
Cytochrome P450 1A1 (CYP1A1) is a member of the multi-
gene family of xenobiotic metabolizing enzymes [4]. Beside itsAbbreviations: ER, endoplasmic reticulum; CYP1A1, cytochrome P4-
50 1A1; AhR, aryl hydrocarbon receptor; 2,3,7,8-TCDD, 2,3,7,8-tet-
rachlorodibenzo-p-dioxin; DRE, dioxin responsive element; SEAP,
secreted alkaline phosphatase; XRE, xenobiotic responsive element;
GRP78, 78-kD glucose-regulated protein; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; AhRDN, dominant-negative mutant of
AhR
*Corresponding author. Fax: +81 55 273 8054.
E-mail address: masanori@yamanashi.ac.jp (M. Kitamura).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.05.061physiological role in the detoxiﬁcation of xenobiotics,
CYP1A1 is also responsible for metabolic activation of polycy-
clic aromatic hydrocarbons and aromatic amines, leading to
generation of genotoxic substances [5]. For example, benzo[a]-
pyrene induces CYP1A1 which in turn metabolizes benzo[a]-
pyrene per se to reactive, carcinogenic intermediates. Mice
having the higher CYP1 levels were, therefore, more suscepti-
ble to various aromatic hydrocarbons-induced pathologies
including liver injury [6].
Expression of cyp1a1 in response to aromatic hydrocarbons is
regulated by the aryl hydrocarbon receptor (AhR), the ligand-
activating transcription factor. Binding of xenobiotic ligands
[e.g., 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD)] to
AhR triggers nuclear translocation of AhR and causes binding
of the AhR-ligand complex to the AhR nuclear translocator in
the nuclei. This molecular event results in binding of the com-
plexes to the dioxin responsive element (DRE, also termed as
xenobiotic responsive element; XRE) in the 5 0 ﬂanking region
of various target genes including cyp1a1 [7].
Recently, we unexpectedly found that tunicamycin induced
expression of cyp1a1 in a murine hepatoma cell line Hepa-
1c1c7. In the present report, we elucidate molecular mecha-
nisms involved in this novel potential of tunicamycin. Our
study especially focuses on involvement of distinct cellular
events that can be triggered by tunicamycin; i.e., protein hypo-
glycosylation, ER stress and activation of the AhR – DRE
signaling pathway.2. Materials and methods
2.1. Cells and reagents
Murine hepatoma cell line Hepa-1c1c7 was purchased from Amer-
ican Type Culture Collection (ATCC; Manassas, VA). The reporter
cell line HeXS34 was established by transfection of Hepa-1c1c7 cells
with pXRE-SEAP, as described previously [8]. pXRE-SEAP encodes
secreted alkaline phosphatase (SEAP) under the control of four
copies of XRE/DRE [8]. 2,3,7,8-TCDD and 2-deoxy-glucose were
obtained from Wako Pure Chemical Industries (Osaka, Japan), and
other reagents were purchased from Sigma–Aldrich, Japan (Tokyo,
Japan). All experiments were performed using a-minimum essential
medium (Invitrogen, Carlsbad, CA) supplemented with 1% fetal
bovine serum.
2.2. Transient transfection
Using lipofectamine 2000 (Invitrogen), Hepa-1c1c7 cells were tran-
siently co-transfected with pGL3-XRE-Luc [9] together with pEFBOS
or pEFBOS-AhR(Arg39Ile) encoding a dominant-negative mutant of
AhR [10]. pGL3-XRE-Luc encodes ﬁreﬂy luciferase under the controlblished by Elsevier B.V. All rights reserved.
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transfection, the cells were treated with tunicamycin (10 lg/ml) or
2,3,7,8-TCDD (100 pM) for 6 h and subjected to luciferase assay, as
described later. Assays were performed in quadruplicate.
2.3. Northern blot analysis
Total RNA was extracted by the single-step method, and Northern
blot analysis was performed as described before [11]. cDNAs for
CYP1A1 [12], SEAP (BD Biosciences, Palo Alto, CA) and 78-kDa
glucose-regulated protein (GRP78) [12] were used to prepare radio-la-
beled probes. Expression of glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) was used as a loading control. Densitometric
analysis was performed using Scion Image (Scion Corporation, Fred-
erick, MO).
2.4. Luciferase assay
Activity of luciferase was evaluated by Luciferase Assay System
(Promega, Madison, WI). In brief, according to the manufacturer’s
protocol, cells were lysed by lysis buﬀer, and activity of luciferase
was evaluated in the presence of luciferin using a luminometer (Gene
Light 55; Microtech Nition, Chiba, Japan).Fig. 2. Dose- and time-dependent activation of the dioxin responsive element
secreted alkaline phosphatase (SEAP) under the control of DRE consensus se
for 6 h (A) or 5.0 lg/ml tunicamycin for indicated time periods (B), and exp
Fig. 1. Dose- and time-dependent induction of cytochrome P450 1A1 (CYP
indicated concentrations of tunicamycin for 6 h (A) or 5.0 lg/ml tunicamycin
by Northern blot analysis. The expression level of glyceraldehyde-3-phosp
control.
Fig. 3. Lack of involvement of endoplasmic reticulum stress and protein h
treated with 1–10 lg/ml tunicamycin for 6 h, and expression of SEAP and g
treated with 5 lg/ml tunicamycin, 2 mM castanospermine or 6 mg/ml 2-deox2.5. Statistical analysis
Data were expressed as means ± S.E. Statistical analysis was per-
formed using the non-parametric Mann–Whitney U test to compare
data in diﬀerent groups. P value <0.05 was considered to indicate a
statistically signiﬁcant diﬀerence.3. Results
3.1. Induction of cyp1a1 mRNA by tunicamycin
We ﬁrst examined a dose-dependent eﬀect of tunicamycin on
the expression of cyp1a1. Hepa-1c1c7 cells were exposed to 0–
5 lg/ml of tunicamycin for 6 h and subjected to Northern blot
analysis. As shown in Fig. 1A, expression of cyp1a1 mRNA
was induced by tunicamycin in a dose-dependent manner. Sub-
stantial induction was observed at concentrations higher than
0.5 lg/ml and peaked to maximum at 2.5–5 lg/ml. Time-lapse
experiments revealed that the induction of cyp1a1 was tran-
sient; i.e., it was peaked at 3 h and declined thereafter (Fig. 1B).(DRE) by tunicamycin. Hepa-1c1c7-derived HeXS34 cells that express
quences were exposed to either indicated concentrations of tunicamycin
ression of SEAP was examined by Northern blot analysis.
1A1) mRNA by tunicamycin. Hepa-1c1c7 cells were exposed to either
for indicated time periods (B), and expression of cyp1a1 was examined
hate dehydrogenase (GAPDH) is shown at the bottom as a loading
ypoglycosylation in the eﬀects of tunicamycin. (A) HeXS34 cells were
rp78 was examined by Northern blot analysis. (B) HeXS34 cells were
y-glucose for 6 h, and expression of cyp1a1 and grp78 was examined.
Fig. 4. Involvement of aryl hydrocarbon receptor (AhR) in the activation of DRE and induction of cyp1a1 by tunicamycin. (A and B) Eﬀects of
resveratrol on 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD)- and tunicamycin-induced activation of DRE and expression of cyp1a1. HeXS34
cells were pretreated with 0–30 lM resveratrol for 30 min, exposed to 25 pM 2,3,7,8-TCDD or 5 lg/ml tunicamycin for 3 h and subjected to Northern
blot analysis of SEAP and cyp1a1. Intensity of individual signals normalized by the levels of GAPDH is shown in (B). (C) Hepa-1c1c7 cells were
transiently co-transfected with pGL3-XRE-Luc together with pEFBOS (closed bars) or pEFBOS-AhR (Arg39Ile) encoding a dominant-negative
mutant of AhR (shaded bars). Forty-eight hours after the transfection, the cells were treated with tunicamycin (10 lg/ml) or 2,3,7,8-TCDD (100 pM)
for 6 h and subjected to luciferase assay. Assays were performed in quadruplicate. Data are expressed as means ± S.E. Asterisks indicate statistically
signiﬁcant diﬀerences (P < 0.05). RLU, relative light unit.
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The 5 0-ﬂanking region of the cyp1a1 gene contains DREs.
These DREs are essential for transcriptional induction of
cyp1a1 by aromatic hydrocarbons including dioxins [4,7]. We
next examined whether tunicamycin can trigger activation of
DRE. For this purpose, Hepa-1c1c7-derived HeXS34 cells
were used. This reporter line expresses SEAP under the control
of the DRE/XRE consensus sequences [8]. As shown in
Fig. 2A, tunicamycin induced activation of DRE in a dose-
dependent manner, which was closely correlated with the
expression level of cyp1a1 (Fig. 1A). The activation was
peaked at 6 h and declined thereafter (Fig. 2B). The similar re-
sult was also obtained using a diﬀerent Hepa-1c1c7-derived re-
porter cells, HeDS49 [13], that express SEAP under the control
of the truncated promoter of the mouse cyp1a1 gene that con-
tains 4 DREs (data not shown).
3.3. Lack of involvement of protein hypoglycosylation and ER
stress in the eﬀects of tunicamycin
Tunicamycin inhibits transfer of N-acetylglucosamine-1-
phosphate from uridine 5-diphosphate-N-acetylglucosamine
to dolichol monophosphate in the ﬁrst step of glycoprotein
synthesis and thereby blocks formation of protein-carbohy-
drate linkages of the N-glycosidic type [14]. Accumulation of
hypoglycosylated proteins in the ER subsequently causes ER
stress and induces the so-called unfolded protein responses
including expression of GRP78 [1]. We examined whether pro-
tein hypoglycosylation or ER stress is causative of induction of
cyp1a1 and activation of DRE by tunicamycin. First, HeXS34
cells were treated with diﬀerent concentrations of tunicamycin,
and the levels of SEAPand grp78, an endogenous marker of
ER stress, were compared by Northern blot analysis. As
shown in Fig. 3A, the level of ER stress indicated by grp78
was not in parallel with the activation level of DRE indicated
by SEAP. For example, 1 lg/ml of tunicamycin fully induced
ER stress whereas activation of DRE was not obvious. This re-
sult indicated that activation of DRE by tunicamycin may be
independent of ER stress. To conﬁrm this conclusion, HeXS34
cells were treated with diﬀerent glycosylation inhibitors, cast-
anospermine and 2-deoxy-glucose, and expression of cyp1a1
and grp78 was examined. Like tunicamycin, both castanosper-
mine and 2-deoxy-glucose substantially induced ER stress indi-
cated by expression of grp78. However, both agents did not
cause induction of cyp1a1 (Fig. 3B). These results suggested
that neither protein hypoglycosylation nor ER stress was caus-
ative of activation of the DRE pathway by tunicamycin.
3.4. Involvement of AhR in the activation of DRE and expression
of cyp1a1 by tunicamycin
In general, DRE is activated via binding of AhR-xenobiotics
complexes [4,7]. We tested whether functional AhR is required
for the eﬀects of tunicamycin on the activation of DRE and
expression of cyp1a1. For this purpose, we used resveratrol,
a pure antagonist of AhR [15]. As shown in Fig. 4A and B,
2,3,7,8-TCDD induced activation of DRE and expression of
cyp1a1 in HeXS34 cells. This induction was inhibited by the
treatment with resveratrol modestly at 20 lM and markedly
at 30 lM. Like its suppressive eﬀect on 2,3,7,8-TCDD, expres-
sion of cyp1a1 triggered by tunicamycin was substantially
inhibited by the treatment with resveratrol, and it was associ-
ated with suppression of DRE activation evidenced by attenu-
ated SEAP mRNA.To further conﬁrm the involvement of AhR in the eﬀects of
tunicamycin, Hepa-1c1c7 cells were transiently transfected with
a dominant-negative mutant of AhR (AhRDN) together with a
luciferase-based DRE reporter plasmid. Northern blot analysis
conﬁrmed high levels of expression of AhRDN in the transfec-
ted cells (data not shown). Using these cells, the eﬀect of tunica-
mycin onDREwas retested. Transfection with AhRDNdid not
aﬀect the basal luciferase activity. As expected, functional sup-
pression of AhR by AhRDN signiﬁcantly inhibited activation
of DRE triggered by 2,3,7,8-TCDD (35.0 ± 17.5% vs. 100% in
control, P < 0.05). AhRDN also substantially inhibited activa-
tion ofDRE triggered by tunicamycin (39.7 ± 19.8% vs. 100% in
control, P < 0.05) (Fig. 4C). These results provided additional
evidence that tunicamycin has the potential for activation of
the AhR – DRE signaling pathway.4. Discussion
Tunicamycin has been used for many years as an inducer of
ER stress as well as an inhibitor of protein glycosylation in the
ﬁelds of cell biology and biochemistry. In the present report,
we elucidated the novel potential of tunicamycin as an activa-
tor of the AhR – DRE signaling pathway. A number of previ-
ous reports showed crucial roles of the AhR – DRE pathway
in various pathologies caused by halogenated and polycyclic
aromatic hydrocarbons [4,7]. These environmental substances
cause toxic eﬀects via induction of DRE-regulated genes that
inhibit mitosis, induce apoptosis and generate toxic metabo-
lites. DREs are also located in the 5 0-regulatory regions of a
variety of inﬂammation-associated genes including: (1) inter-
leukins and chemokines; (2) cytokine receptors and adhesion
receptors; (3) enzymes involved in synthesis of nitric oxide,
prostaglandins and lipoxygenases; and (4) molecules involved
in the NF-jB pathway [16]. Therefore, the current ﬁnding that
tunicamycin has the potential for activating the DRE – AhR
pathway raises a possibility that this agent may aﬀect not only
protein glycosylation and ER function but also inﬂuence a di-
verse range of other cellular events. For example, in vivo toxic-
ity of tunicamycin in the liver and the lung [3] could be caused
by the activation of the AhR – DRE pathway. It should be
emphasized that the triggering eﬀect of tunicamycin on the
AhR – DRE pathway must be considered carefully if this agent
is used as a ‘‘selective’’ inhibitor of protein glycosylation and/
or inducer of ER stress under in vitro and in vivo situations.
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